Table: OncoTherapy Science -2025/26 group results

OncoTherapy Science

08/05/2026 09:00

May 8 (Reuters)- 
          OncoTherapy Science Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          808 mln         750 mln                               
               (+7.8 pct)      (+22.9 pct)                             
  Operating   loss 810 mln    loss 797 mln                             
  Recurring   loss 845 mln    loss 815 mln                             
  Net
  Net         loss 910 mln    loss 815 mln                             
  EPS         loss 2.77 yen   loss 3.12 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - OncoTherapy Science Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T